Kestra Medical Technologies Ltd. (KMTS)

26.52 -0.44 (-1.65%) USD  |  NASDAQ  |  Dec 31, 16:00
26.62 +0.10 (+0.38%) After-Hours: 20:00
More

Kestra Medical Technologies Research and Development Expense (TTM): 17.62M for Oct. 31, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for KMTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Bruker Corp. 400.00M
Azenta, Inc. 28.19M
Harvard Bioscience, Inc. 8.97M
Precipio, Inc. --
Bionano Genomics, Inc. 11.62M